NextCure
NXTC
43 hedge funds and large institutions have $21.7M invested in NextCure in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.
0.54% less ownership
Funds ownership: 57.24% → 56.7% (-0.54%)
10% less funds holding
Funds holding: 48 → 43 (-5)
15% less capital inflows, than outflows
Capital inflows: $1.25M | Capital outflows: $1.48M
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Affinity Asset Advisors
New York
|
+$943K |
| 2 |
Armistice Capital
New York
|
+$98.1K |
| 3 |
Tang Capital Management
San Diego,
California
|
+$75.7K |
| 4 |
ADAR1 Capital Management
Austin,
Texas
|
+$47.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$592K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$357K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$152K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$147K |
| 5 |
Renaissance Technologies
New York
|
-$86.1K |
NXTC Hedge Fund Activity: Q3 2024 in Review
43 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q3 2024, worth a combined $21.7M — down 15% from $25.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NXTC and 2 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Affinity Asset Advisors, adding an estimated $943K. The largest seller was Millennium Management, cutting an estimated $592K.
- 43 institutional investors held NextCure (NXTC) as of Q3 2024, down from 48 in Q2 2024.
- Funds reported $21.7M of NextCure stock for Q3 2024, down 15% quarter-over-quarter.
- 2 funds opened new NextCure positions in Q3 2024 and 7 closed out, a net change of -5 holders.
- The largest NextCure buyer in Q3 2024 was Affinity Asset Advisors, an estimated $943K added.
- The largest NextCure seller in Q3 2024 was Millennium Management, an estimated $592K sold.
Based on aggregated 13F filings for Q3 2024.